Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$14.32 - $19.88 $2,090 - $2,902
-146 Reduced 52.71%
131 $2,000
Q1 2022

May 11, 2022

SELL
$15.39 - $20.25 $538 - $708
-35 Reduced 11.22%
277 $5,000
Q4 2021

Jan 10, 2022

BUY
$15.91 - $18.72 $604 - $711
38 Added 13.87%
312 $5,000
Q3 2021

Nov 24, 2021

BUY
$13.06 - $17.24 $3,578 - $4,723
274 New
274 $5,000
Q1 2021

Apr 29, 2021

SELL
$11.06 - $12.87 $707 - $823
-64 Closed
0 $0
Q2 2020

Jul 10, 2020

BUY
$11.49 - $15.26 $735 - $976
64 New
64 $1,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.